Medication info
Richstar Tablet 80/5 mg

Richstar Tablet 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Poonglim Pharm Co., Ltd.
Appearance
White, oval tablet with a biconvex shape
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201607292 · Approved 2016.12.27

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administered’). In older adults aged 75 years and above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Poonglim Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can effectively lower blood pressure and manage hypertension in patients with essential hypertension who do not have adequate blood pressure control with telmisartan or amlodipine monotherapy. This helps reduce the risk of complications such as cardiovascular diseases and strokes. This medication stabilizes blood pressure and improves the overall health status of patients.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administered’). In older adults aged 75 years and above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must not be taken during pregnancy. This medication should not be administered to individuals who are allergic to the active ingredients or similar substances, pregnant women, nursing mothers, or patients with severe liver or heart problems. Particular caution is required when administering this medication to patients with liver disease, certain heart valve diseases, severely reduced kidney function, and those with hypotension. As this medication lowers blood pressure, there may be a risk of hypotension, dizziness, or drowsiness, and caution should be exercised when driving or operating machinery. Due to the risk of increased potassium levels in the blood, patients with impaired kidney function or at risk of hyperkalemia should have regular blood tests. This medication can interact with other drugs, so especially in the case of patients taking certain heart medications, diuretics, lithium, warfarin, and nonsteroidal anti-inflammatory drugs (NSAIDs), consultation with a doctor or pharmacist is necessary. In case of overdose, symptoms such as hypotension, irregular heartbeat, dizziness, and acute renal failure may occur, and immediate medical attention should be sought. Safety and efficacy have not been sufficiently established for children and adolescents under 18 years old, so use is not recommended. It is important to store this medication out of the reach of children and to keep it in its original packaging.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic cutaneous eruption
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • arthralgia
  • muscle cramps
  • joint pain
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • increased urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-protected container. It is also best to store it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

White, oval tablet with a biconvex shape

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.